Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Immunoassay Markets, 2025 - Increasing Use of Immunoassays in Oncology | ||
By: PR Newswire Association LLC. - 16 Aug 2019 | Back to overview list |
|
DUBLIN, Aug. 16, 2019 /PRNewswire/ -- The "Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global immunoassay market is expected to grow at a CAGR of 5.9% from 2019 to reach $19.76 billion by 2025. The high growth of immunoassays market is attributed to factors such as increasing incidences of chronic and infectious diseases, increasing the use of immunoassay in oncology, rise in drug and alcohol testing, and technological advancements in immunoassay. On the other hand, limitations of immunoassay and development of alternative technologies are expected to hinder the adoption of immunoassay products. Emerging markets and increasing epidemic potentials offer significant growth opportunities for the players operating in this market. On the basis of product, immunoassay kits and reagents segment is estimated to account for the largest share of this market in 2019. The large share of this segment is mainly attributed to the increasing number of immunoassay tests being performed across the globe leading to the recurrent purchase of kits and reagents. Among kits and reagents segment, ELISpot kits and reagents segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot assay kits and analyzers. On the basis of application, infectious diseases segment is estimated to account for the largest share of the immunoassay market in 2019, mainly due to the rising incidence of infectious diseases and growing adoption of immunoassay diagnostics in infectious diseases. However, the oncology segment is expected to grow at the highest CAGR in the forecast period. Rising prevalence of cancer, increasing focus towards tumor market development, technological advancements, and growing awareness about cancer are expected to drive the growth of this market. An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America accounted for the largest share of immunoassays market, mainly due to rising incidence of infectious diseases, growing prevalence of cancer, rising healthcare expenditure, presence of major players for immunoassay in the region, and highly developed healthcare infrastructure. Key Topics Covered: 1. Introduction For more information about this report visit https://www.researchandmarkets.com/r/9jwpzh Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Laura Wood, Senior Manager View original content:http://www.prnewswire.com/news-releases/immunoassay-markets-2025---increasing-use-of-immunoassays-in-oncology-300903020.html SOURCE Research and Markets |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |